Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunnar Aus

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer|March 26, 2010
Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, SwedenAndrew J Vickers, Angel M Cronin, Gunnar Aus, et al.
Scandinavian Journal of Urology|December 20, 2017
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortalityJonas Hugosson, Rebecka Arnsrud Godtman, Sigrid V Carlsson, et al.
The Journal of Urology|April 15, 2022
Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening TrialMaria Frånlund, Marianne Månsson, Rebecka Arnsrud Godtman, et al.
BJU International|October 19, 2010
No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate CancerSigrid V Carlsson, Erik Holmberg, Sue M Moss, et al.
European Urology|January 4, 2016
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening TrialAnna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
International Journal of Cancer|October 3, 2006
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden sectionAli Khatami, Khatami Ali, Gunnar Aus, et al.
European Urology|September 25, 2016
Corrigendum re: "Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial" [Eur Urol 2016;70:566-73]Anna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
European Urology|September 23, 2008
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantlyRoderick C N van den Bergh, Stijn Roemeling, Monique J Roobol, et al.
BJU International|January 22, 2009
Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 menRoderick C N van den Bergh, Stijn Roemeling, Monique J Roobol, et al.
The Journal of Urology|July 21, 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer|March 26, 2010
Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, SwedenAndrew J Vickers, Angel M Cronin, Gunnar Aus, et al.
Scandinavian Journal of Urology|December 20, 2017
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortalityJonas Hugosson, Rebecka Arnsrud Godtman, Sigrid V Carlsson, et al.
The Journal of Urology|April 15, 2022
Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening TrialMaria Frånlund, Marianne Månsson, Rebecka Arnsrud Godtman, et al.
BJU International|October 19, 2010
No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate CancerSigrid V Carlsson, Erik Holmberg, Sue M Moss, et al.
European Urology|January 4, 2016
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening TrialAnna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
International Journal of Cancer|October 3, 2006
PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden sectionAli Khatami, Khatami Ali, Gunnar Aus, et al.
European Urology|September 25, 2016
Corrigendum re: "Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial" [Eur Urol 2016;70:566-73]Anna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
European Urology|September 23, 2008
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantlyRoderick C N van den Bergh, Stijn Roemeling, Monique J Roobol, et al.
BJU International|January 22, 2009
Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 menRoderick C N van den Bergh, Stijn Roemeling, Monique J Roobol, et al.
The Journal of Urology|July 21, 2010
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyAndrew J Vickers, Tineke Wolters, Caroline J Savage, et al.
Pageof 7